Healthcare Finance in 2026: How Rising Costs, Reimbursement Uncertainty, and Outpatient Growth Are Reshaping Practice Value

By Bruce G. Krider MHA, American Healthcare Appraisal

Healthcare organizations are entering 2026 with a mix of opportunity and risk. Revenue is rising, patient volume is strong, and outpatient care continues to expand at a pace unmatched in prior years. Yet beneath those encouraging signals lies a financial environment defined by cost inflation, reimbursement uncertainty, and operational strain. For medical practices, hospitals, and buyers and sellers across the healthcare ecosystem, these forces directly influence how practices are valued—and how they should prepare for the future.

Gross operating revenue rose 11.4% year‑over‑year, with outpatient revenue increasing 12.8% and inpatient revenue up 9.8%. Healthy volume gains contributed to these increases, with outpatient visits rising 9.8% and inpatient admissions up 5.3%.

But the picture is far from simple. Expenses climbed 7.5% year‑over‑year, and labor costs alone rose 4.3% as competition for clinical and administrative staff intensified. More than 80% of CFOs now cite financial conditions as their top concern heading into 2026.

This combination—strong revenue, rising costs, and deep uncertainty—creates a valuation environment where independent, expert analysis is more important than ever.

The Financial Pressures Defining 2026

Healthcare leaders face simultaneous pressures that make financial planning difficult:

• Cost inflation across labor, supplies, and technology

• Potential reimbursement losses, especially from Medicaid and other government programs

• Cybersecurity threats that require ongoing investment

• Growth imperatives, particularly in outpatient care

• Leadership anxiety, with 84% of administrative and clinical leaders citing financial pressures as their greatest threat for the coming year

Margins remain positive but thin. Hospital operating margins averaged 2.9% in 2025, and median health system margins were just 1.1%.

For valuation professionals, these numbers matter. They shape risk profiles, influence discount rates, and determine how sustainable a practice’s financial performance truly is.

Outpatient and ASC Growth: The Most Important Shift for Practice Value

If there is one trend reshaping healthcare economics more than any other, it is the rapid expansion of outpatient care.

Outpatient volume is projected to increase 18% through 2035, compared to just 5% for inpatient services. Ambulatory Surgery Centers (ASCs) continue to gain ground, with 51% of eligible surgeries already performed in ASCs by 2024 and volume expected to rise another 9% between 2023 and 2028.

Why this matters for valuation

• Outpatient‑aligned practices often command higher multiples due to lower overhead and stronger margins.

• Buyers are aggressively targeting specialties that thrive in ASC and outpatient environments—orthopedics, GI, ophthalmology, pain management, and dermatology.

• Practices with efficient outpatient workflows and strong patient throughput are viewed as lower‑risk, higher‑return assets.

For sellers, this environment can create competitive bidding and stronger enterprise value. For buyers, it requires sharper due diligence and a deeper understanding of reimbursement exposure.

Reimbursement Cuts and Policy Volatility: A Direct Hit to Value

Government reimbursement remains one of the most unpredictable forces in healthcare finance. Medicaid and other government program cuts are a substantial overhang for 2026, and even practices with strong patient volume face uncertainty about future revenue streams.

How reimbursement risk affects valuation

• Higher uncertainty increases the discount rate in income‑based valuation models.

• Practices with heavy government payer mix may see lower valuation multiples.

• Buyers are scrutinizing coding patterns, payer mix, and audit exposure more aggressively than ever.

In a volatile reimbursement environment, the quality of a practice’s revenue becomes just as important as the quantity.

Rising Costs and Their Impact on EBITDA

Even with strong revenue growth, rising expenses continue to erode margins. Labor costs rose 4.3% in 2025, and total hospital expenses increased 7.5% year‑over‑year.

Cost drivers that distort valuation

• Wage inflation and contract staffing

• Technology and cybersecurity investments

• Supply chain volatility

• Increased administrative burden

For valuation, this means EBITDA must be carefully normalized to remove temporary cost spikes and identify sustainable earnings. Buyers increasingly request multi‑year adjusted EBITDA to smooth volatility and assess long‑term performance.

Practices with stable cost structures and disciplined financial management stand out in this environment.

Automation and AI: The Quiet Force Changing Healthcare Finance

Automation and AI are accelerating across healthcare finance, from revenue cycle management to digital payment rails. These technologies promise efficiency gains, reduced administrative overhead, and improved cash flow.

Implications for valuation

• Practices that adopt automation may show higher margins and more predictable cash flow.

• Buyers view tech‑enabled practices as lower‑risk and more scalable.

• Over time, automation may widen the valuation gap between modernized and legacy practices.

This is a strategic opportunity for practices preparing for sale in the next 12–36 months.

What All This Means for Practice Valuation in 2026

The financial environment of 2026 creates both challenges and opportunities:

• High‑performing outpatient practices may see rising valuations.

• Practices with heavy government payer mix may face downward pressure.

• Cost‑efficient, tech‑enabled practices will command stronger multiples.

• Volatile financials require expert normalization, making independent valuation essential.

For buyers, sellers, attorneys, and CPAs, the message is clear: valuation in 2026 cannot rely on outdated assumptions. It requires a nuanced understanding of reimbursement risk, cost structure, outpatient growth, and the operational realities shaping healthcare finance.

Closing Thought

The organizations that thrive in 2026 will be those that understand how these financial forces interact—and take proactive steps to strengthen their position. Independent valuation is no longer a formality; it is a strategic tool for navigating one of the most complex financial environments healthcare has seen in years.